Transgenic Mouse Model With Modified Pak Inhibitor Domain
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current transgenic mouse models for studying Pak function are limited, as they either lack endogenous Pak activity or have wide-ranging effects due to non-tissue-specific expression, making it difficult to evaluate Pak's role in development and disease models like cancer and neurologic diseases.
Innovation Solution
A transgenic mouse model expressing a modified p21-activated kinase (Pak) inhibitor domain (PID) linked to GST, stably integrated into the mouse genome for constitutive expression in specific tissues, allowing for tissue-specific manipulation of Pak activity using the CRE-Lox recombination system.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If Pak knock-out mice are used to study Pak function, then Pak activity is completely eliminated, but endogenous Pak activity is lost making it difficult to evaluate Pak's role in development and disease
Solution Approach 1:
The invention extracts only the inhibitor domain (PID) from the full Pak protein and expresses it as a separate entity. This PID acts as a dominant-negative inhibitor that selectively blocks Pak activity without requiring complete knockout of the Pak gene, thereby preserving endogenous Pak expression while enabling functional evaluation.
Solution Approach 2:
The modified PID serves as an intermediary molecule that mediates the inhibition of Pak activity. By expressing this intermediate inhibitor domain, the system allows controlled modulation of Pak function rather than complete elimination, enabling more nuanced evaluation of Pak's physiological roles.
2Reliability
If transgenic mice express dominant negative kinase-dead Pak1, then Pak activity is inhibited, but expression is not tissue-specific causing wide-ranging effects
Solution Approach 1:
The invention implements local quality by creating tissue-specific expression patterns of the modified PID. Different transgenic mouse lines express the inhibitor domain in specific tissues (e.g., forebrain, skin, gastrointestinal tract), allowing evaluation of Pak's role in particular tissue contexts without confounding systemic effects.
3Measurement precision
If complete Pak knockout is performed, then Pak function is eliminated, but developmental compensation occurs making it difficult to interpret results
Solution Approach 1:
Instead of complete Pak elimination, the invention applies partial action by expressing the modified PID at controlled levels. This partial inhibition approach prevents complete knockout-related compensation while still providing sufficient inhibition to evaluate Pak's functional role, achieving better measurement precision.
Data Source
AI summary
Mice comprising a modified p21-activated kinase (Pak) inhibitor domain (PID*), optionally linked with GST and capable of constitutive expression of PID are provided. Also provided are cells, tissue, and organs obtainable from such mice, and methods for producing mice comprising a modified p21-activated kinase (Pak) inhibitor domain (PID*).